Aishwarya Vaidya
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: Aishwarya Vaidya | Updated : August 1, 2018 11:43 AM IST
A progressive nervous system disorder that affects movement can be termed as Parkinson s. One may experience stiffness and slow moments along with tremors. This can deteriorate the quality of life of the person and also they won t be able to carry out their daily chores with ease. So, for people with Parkinson s disease, this news can be helpful as they can get themselves back on track. Read on to know more
As a means of curing Parkinson s disease, Japanese scientists have just been given permission by the government to begin clinical trials for reprogrammed stem cells which can cure Parkinson s disease. Reportedly, Jun Takahashi, a neurosurgeon at Kyoto University s Centre for iPS Cell Research and Application, into
Parkinson's patients brains, dopamine-producing neural progenitor cells which are derived from induced pluripotent stem cells (IPSCs) form adult donors who are healthy will be injected by Takahashi and his colleagues. Also, the team will have 7 participants who will be observed for two years once they are injected with the dopamine-producing neural progenitor cells. Speaking about the injection, into the patients striatum approximately 5 million cells will be injected.
According to Jun Takahashi, By using (induced pluripotent stem) cells on Parkinson s disease, be the world s first clinical trial.
Earlier, the scientists were concerned that the application of these cells can result into malignant tumours. However, in the last year, it was reported by Takahashi and his colleagues that for two years, the injected cells can survive in the monkey brains and in a primate model of Parkinson s disease, the treatment improved the symptoms.
This is the third iPSC clinical trial approved in Japan, as per science. Treating age-related macular degeneration and heart disease are the other two trails. Hopefully, the Parkinson s patients will benefit from it in the near future.
Image Source: Shutterstock
Disclaimer: The content on TheHealthSite.com is only for informational purposes. It is not at all professional medical advice. Always consult your doctor or a healthcare specialist for any questions regarding your health or a medical condition.